Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1953 Mar 31;97(4):573–589. doi: 10.1084/jem.97.4.573

THE INACTIVATION OF COMPLEMENT AND ITS COMPONENTS BY PLASMIN

Louis Pillemer 1, Oscar D Ratnoff 1, Livia Blum 1, I H Lepow 1
PMCID: PMC2136289  PMID: 13052820

Abstract

Human complement is inactivated by plasmin, the proteolytic enzyme of plasma or serum active at or near neutrality. The addition of streptokinase to human serum, which converts plasminogen to plasmin, also causes the inactivation of complement components C'2 and C'4 and varying amounts of C'1. C'3 is the most resistant to inactivation by plasmin. Chloroform-activated human plasmin and bovine plasmin also destroy these components of complement, but are less effective than the streptokinase-activated enzyme. The inactivation of complement by the addition of streptokinase to human serum is inhibited by high hydrogen ion concentrations, low temperature, and elevated ionic strength. The inactivation of the components of complement in various fractions of serum is influenced by the available plasminogen and the content of plasmin inhibitors in these fractions. Certain similarities are pointed out between the components of complement and the factors in the plasmin system and between the inactivation of the components of complement by antigen-antibody reactions, by specific agents, and by plasmin. The possible significance of these relationships in immune hemolysis and complement fixation, and the possible role of the plasmin system in the instability of complement and the development of anticomplementary properties in serum are discussed.

Full Text

The Full Text of this article is available as a PDF (895.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bier O. G., Leyton G., Mayer M. M., Heidelberger M. A COMPARISON OF HUMAN AND GUINEA PIG COMPLEMENTS AND THEIR COMPONENT FRACTIONS. J Exp Med. 1945 May 1;81(5):449–468. doi: 10.1084/jem.81.5.449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. CLIFFTON E. E., DOWNIE G. R. Variations in proteolytic activity of serum of animals including man. Proc Soc Exp Biol Med. 1950 Apr;73(4):559–562. doi: 10.3181/00379727-73-17743. [DOI] [PubMed] [Google Scholar]
  3. GEIGER W. B. Protease activation in immune reactions. J Immunol. 1952 Jan;68(1):11–18. [PubMed] [Google Scholar]
  4. Hedin S. G. On the presence of a proteolytic enzyme in the normal serum of the ox. J Physiol. 1903 Nov 2;30(2):195–201. doi: 10.1113/jphysiol.1903.sp000989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. LEWIS J. H., HOWE A. C., FERGUSON J. H. Thrombin formation; effects of lysin (fibrinolysin, plasmin) on prothrombin, Ac-globulin and tissue thromboplastin. J Clin Invest. 1949 Nov;28(6 Pt 2):1507–1510. doi: 10.1172/JCI102216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Mayer M. M., Osler A. G., Bier O. G., Heidelberger M. THE ACTIVATING EFFECT OF MAGNESIUM AND OTHER CATIONS ON THE HEMOLYTIC FUNCTION OF COMPLEMENT. J Exp Med. 1946 Nov 30;84(6):535–548. doi: 10.1084/jem.84.6.535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Pillemer L., Ecker E. E., Oncley J. L., Cohn E. J. THE PREPARATION AND PHYSICOCHEMICAL CHARACTERIZATION OF THE SERUM PROTEIN COMPONENTS OF COMPLEMENT. J Exp Med. 1941 Sep 30;74(4):297–308. doi: 10.1084/jem.74.4.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Pillemer L., Ecker E. E. THE TERMINOLOGY OF THE COMPONENTS OF COMPLEMENT. Science. 1941 Nov 7;94(2445):437–437. doi: 10.1126/science.94.2445.437. [DOI] [PubMed] [Google Scholar]
  9. Pillemer L., Seifter S., Chu F., Ecker E. E. FUNCTION OF COMPONENTS OF COMPLEMENT IN IMMUNE HEMOLYSIS. J Exp Med. 1942 Jul 1;76(1):93–101. doi: 10.1084/jem.76.1.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Pillemer L., Seifter S., Ecker E. E. THE ROLE OF THE COMPONENTS OF COMPLEMENT IN SPECIFIC IMMUNE FIXATION. J Exp Med. 1942 Apr 1;75(4):421–435. doi: 10.1084/jem.75.4.421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. RATNOFF O. D. Studies on a proteolytic enzyme in human plasma. VIII. The effect of calcium and strontium ions on the activation of the plasma proteolytic enzyme. J Exp Med. 1952 May;95(5):319–329. doi: 10.1084/jem.96.4.319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. RATNOFF O. D. Studies on a proteolytic enzyme in human plasma; the probable identity of the enzymes activated by chloroform and by filtrates of cultures of beta hemolytic streptococci. J Exp Med. 1948 Mar 1;87(3):199–209. doi: 10.1084/jem.87.3.199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Seegers W. H., Loomis E. C. Prothrombin and Fibrinolysin. Science. 1946 Nov 15;104(2707):461–462. doi: 10.1126/science.104.2707.461. [DOI] [PubMed] [Google Scholar]
  14. UNGAR G., MIST S. H. Observations on the release of serum fibrinolysin by specific antigen, peptone, and certain polysaccharides. J Exp Med. 1949 Jul;90(1):39–51. doi: 10.1084/jem.90.1.39. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES